Massachusetts Financial Services Co. MA decreased its position in Chemed Co. (NYSE:CHE - Free Report) by 46.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,859 shares of the company's stock after selling 92,827 shares during the period. Massachusetts Financial Services Co. MA owned approximately 0.72% of Chemed worth $57,144,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the company. Cerity Partners LLC lifted its holdings in Chemed by 30.8% in the third quarter. Cerity Partners LLC now owns 849 shares of the company's stock valued at $510,000 after acquiring an additional 200 shares during the period. HighTower Advisors LLC grew its holdings in Chemed by 78.0% during the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock valued at $2,246,000 after purchasing an additional 1,634 shares during the period. Quantinno Capital Management LP increased its position in Chemed by 29.9% in the third quarter. Quantinno Capital Management LP now owns 1,587 shares of the company's stock worth $954,000 after buying an additional 365 shares in the last quarter. Quadrature Capital Ltd bought a new position in shares of Chemed in the third quarter worth about $1,411,000. Finally, Stifel Financial Corp grew its stake in shares of Chemed by 1.0% during the 3rd quarter. Stifel Financial Corp now owns 26,996 shares of the company's stock valued at $16,224,000 after acquiring an additional 273 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CHE has been the subject of several recent analyst reports. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada upped their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th.
Get Our Latest Report on Chemed
Chemed Stock Down 0.5 %
CHE traded down $2.92 on Thursday, hitting $585.12. The company had a trading volume of 23,459 shares, compared to its average volume of 96,473. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $627.12. The business's fifty day simple moving average is $581.75 and its 200 day simple moving average is $567.98. The company has a market cap of $8.56 billion, a PE ratio of 29.54, a PEG ratio of 2.15 and a beta of 0.49.
Chemed Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio (DPR) is 10.05%.
Insider Activity at Chemed
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.32% of the stock is currently owned by insiders.
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.